Basic Information
| LncRNA/CircRNA Name | AB007962 |
| Synonyms | LINC00869 |
| Region | NA |
| Ensemble | ENSG00000277147 |
| Refseq | NR_046135 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR, other |
| Sample | GC tissues |
| Expression Pattern | down-regulated |
| Function Description | In conclusion, it was determined that the expression level of AB007962 was significantly reduced, compared with matched NATs in GC tissues (P=0.003). Survival analysis indicated that patients with intestinal-type GC with a reduced expression of AB007962 had a reduced prognosis, compared with those with an increased expression. AB007962 may be involved in the progression of GC and act as a novel prognostic biomarker for patients with GC, particularly in intestinal-type GC. |
| Pubmed ID | 30214597 |
| Year | 2018 |
| Title | Long Non-Coding RNA AB007962 Is Downregulated in Gastric Cancer and Associated With Poor Prognosis |
External Links
| Links for AB007962 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |